Feener Edward P.
Insider CIK 1691090 · KALV Chief Scientific Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KALV KalVista Pharmaceuticals, | S Sale | 2024-05-20 | 2024-05-21 | 8,088 | $11.76 | $95.1K | 72,858 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-05-17 | 2024-05-21 | 2,431 | — | $0 | 14,583 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-05-17 | 2024-05-21 | 7,292 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-05-17 | 2024-05-21 | 7,292 | — | $0 | 14,583 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-05-17 | 2024-05-21 | 1,774 | — | $0 | 14,190 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2024-05-17 | 2024-05-21 | 18,789 | — | $0 | 80,946 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2024-02-20 | 2024-02-21 | 8,397 | $14.11 | $118.5K | 82,048 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2024-02-20 | 2024-02-21 | 19,591 | $14.04 | $275.1K | 62,457 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2024-02-20 | 2024-02-21 | 300 | $14.72 | $4.4K | 62,157 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-02-17 | 2024-02-21 | 2,430 | — | $0 | 17,014 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-02-17 | 2024-02-21 | 7,292 | — | $0 | 7,292 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-02-17 | 2024-02-21 | 7,292 | — | $0 | 21,875 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-02-17 | 2024-02-21 | 1,774 | — | $0 | 15,964 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2024-02-17 | 2024-02-21 | 18,788 | — | $0 | 90,445 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2024-02-14 | 2024-02-16 | 28,171 | $15.01 | $422.8K | 71,657 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2024-02-11 | 2024-02-13 | 29,167 | — | $0 | 29,167 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award | 2024-02-11 | 2024-02-13 | 60,000 | — | $0 | 99,828 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2024-01-11 | 2024-01-12 | 22,679 | $13.03 | $295.5K | 39,828 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2024-01-09 | 2024-01-10 | 100 | $13.00 | $1.3K | 62,507 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2024-01-08 | 2024-01-10 | 17,221 | $13.01 | $224.0K | 62,607 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2023-11-20 | 2023-11-21 | 4,958 | $8.23 | $40.8K | 79,828 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-11-17 | 2023-11-21 | 7,292 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-11-17 | 2023-11-21 | 1,774 | — | $0 | 17,738 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-11-17 | 2023-11-21 | 2,431 | — | $0 | 19,444 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2023-11-17 | 2023-11-21 | 11,497 | — | $0 | 84,786 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2023-08-18 | 2023-08-21 | 4,976 | $10.73 | $53.4K | 73,289 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-08-17 | 2023-08-21 | 1,773 | — | $0 | 19,512 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-08-17 | 2023-08-21 | 7,291 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-08-17 | 2023-08-21 | 2,430 | — | $0 | 21,875 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2023-08-17 | 2023-08-21 | 11,494 | — | $0 | 78,265 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2023-05-18 | 2023-05-19 | 1,786 | $10.14 | $18.1K | 66,771 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-05-17 | 2023-05-19 | 2,431 | — | $0 | 24,305 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-05-17 | 2023-05-19 | 1,774 | — | $0 | 21,285 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2023-05-17 | 2023-05-19 | 4,205 | — | $0 | 68,557 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-02-17 | 2023-05-22 | 2,430 | — | $0 | 26,736 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-02-17 | 2023-02-23 | 2,430 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-02-17 | 2023-02-23 | 1,774 | — | $0 | 23,059 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2023-02-17 | 2023-02-23 | 4,204 | — | $0 | 66,580 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2023-02-17 | 2023-02-23 | 2,228 | $7.66 | $17.1K | 64,352 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2023-01-11 | 2023-05-19 | 29,166 | — | $0 | 29,166 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2022-11-18 | 2022-11-21 | 530 | $5.44 | $2.9K | 62,376 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2022-11-17 | 2022-11-21 | 1,774 | — | $0 | 24,833 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2022-11-17 | 2022-11-21 | 1,774 | — | $0 | 62,906 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2022-08-17 | 2022-08-19 | 1,773 | — | $0 | 26,607 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2022-08-17 | 2022-08-19 | 532 | $14.96 | $8.0K | 61,132 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2022-08-17 | 2022-08-19 | 1,773 | — | $0 | 61,664 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2022-05-17 | 2022-05-19 | 28,380 | — | $0 | 28,380 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2022-05-17 | 2022-05-19 | 18,920 | — | $0 | 18,920 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2022-01-07 | 2022-01-11 | 23,857 | — | $0 | 27,943 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2022-01-07 | 2022-01-11 | 33,800 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2022-01-07 | 2022-01-11 | 23,857 | $8.21 | $195.9K | 59,891 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2022-01-07 | 2022-01-11 | 33,800 | $7.07 | $239.0K | 36,034 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2021-11-01 | 2021-11-03 | 6,000 | $18.07 | $108.4K | 2,234 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2021-08-02 | 2021-08-04 | 6,000 | $20.52 | $123.1K | 8,234 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2021-06-02 | 2021-06-03 | 7,138 | $26.33 | $187.9K | 15,296 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2021-06-02 | 2021-06-03 | 1,062 | $27.05 | $28.7K | 14,234 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2021-06-01 | 2021-06-03 | 25,786 | $26.81 | $691.3K | 22,448 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2021-06-01 | 2021-06-03 | 14 | $27.21 | $381 | 22,434 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2021-05-26 | 2021-05-28 | 60,000 | — | $0 | 60,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2021-05-03 | 2021-05-06 | 6,000 | — | $0 | 20,255 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2021-05-03 | 2021-05-06 | 6,000 | $10.21 | $61.3K | 60,234 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2021-05-03 | 2021-05-06 | 6,000 | $24.84 | $149.0K | 54,234 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2021-05-03 | 2021-05-07 | 6,000 | $24.84 | $149.0K | 48,234 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2021-02-23 | 2021-02-25 | 23,441 | $33.72 | $790.4K | 60,505 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2021-02-23 | 2021-02-25 | 5,471 | $32.97 | $180.4K | 55,034 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2021-02-23 | 2021-02-25 | 800 | $31.73 | $25.4K | 54,234 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2021-02-23 | 2021-02-25 | 1,288 | $35.19 | $45.3K | 83,946 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2021-02-07 | 2021-02-08 | 22,500 | — | $0 | 22,500 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2021-02-07 | 2021-02-08 | 20,000 | — | $0 | 20,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award | 2021-02-07 | 2021-02-08 | 12,500 | — | $0 | 85,234 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2020-12-16 | 2020-12-18 | 65,000 | — | $0 | 65,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2020-11-02 | 2020-11-04 | 6,000 | $17.14 | $102.8K | 72,734 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2020-10-21 | 2020-10-22 | 5,407 | $18.75 | $101.4K | 78,734 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2020-10-21 | 2020-10-22 | 3,600 | $17.65 | $63.5K | 84,141 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2020-10-20 | 2020-10-22 | 2,300 | $18.00 | $41.4K | 87,741 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2020-10-20 | 2020-10-22 | 5,600 | $17.26 | $96.7K | 90,041 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2020-10-16 | 2020-10-20 | 993 | $17.00 | $16.9K | 95,641 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2020-02-05 | 2020-02-07 | 100 | $17.11 | $1.7K | 96,634 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2019-07-23 | 2019-07-24 | 1,900 | $18.65 | $35.4K | 96,734 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2019-07-22 | 2019-07-24 | 1,400 | $18.57 | $26.0K | 98,634 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2019-05-15 | 2019-05-17 | 20,250 | — | $0 | 20,250 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2019-04-17 | 2019-04-18 | 3,084 | $24.78 | $76.4K | 100,950 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2019-04-17 | 2019-04-18 | 916 | $25.39 | $23.3K | 100,034 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2019-01-16 | 2019-01-18 | 2,300 | $19.81 | $45.6K | 104,034 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2019-01-16 | 2019-01-18 | 1,700 | $19.20 | $32.6K | 106,334 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2018-09-18 | 2018-09-20 | 52,600 | — | $0 | 52,600 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award | 2018-09-18 | 2018-09-20 | 12,500 | — | $0 | 110,534 | SEC↗ |
| KALV KalVista Pharmaceuticals, | F Tax w/h | 2018-09-18 | 2018-09-20 | 2,500 | $17.05 | $42.6K | 108,034 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2018-06-04 | 2018-06-06 | 51,800 | — | $0 | 51,800 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2017-05-25 | 2017-05-26 | 33,800 | — | $0 | 33,800 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2016-11-28 | 2016-11-30 | 20,055 | — | $0 | 20,055 | SEC↗ |